Evidence map›Paper›PMID 29693659›Full record

ArticleNature microbiology2018

A high-frequency phenotypic switch links bacterial virulence and environmental survival in Acinetobacter baumannii.

Chui Yoke Chin, Kyle A Tipton, Marjan Farokhyfar, Eileen M Burd, David S Weiss, Philip N Rather

Abstract readLetter
In one paragraph

Article in Nature microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed
4.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 162 citations in OpenAlex.

  1. Disruption ofVirulence · 2026
    Article
  2. Article
  3. Microbe Profile:Microbiology (Reading, England) · 2026
    Review
  4. ISmLife · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cell wall remodeling-dependent morphotype switch inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Journal of bacteriology · 2026
    Article
  19. Article
  20. Carnosol attenuatesVirulence · 2025
    Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Chui Yoke ChinEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
Kyle A TiptonDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Marjan FarokhyfarResearch Service, Atlanta VA Medical Center, Decatur, GA, USA.
Eileen M BurdDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
David S WeissEmory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. david.weiss@emory.edu.ORCID 0000-0003-0980-7866
Philip N RatherEmory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA, USA. prather@emory.edu.ORCID 0000-0001-9674-6250
Emory University · USEmory Healthcare · USAtlanta VA Medical Center · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
ArmR: a novel drug target and mediator of antibiotic resistanceR33AI098800 · NIAID · EMORY UNIVERSITY · PI WEISS, DAVID S · 2014 to 2016
$1.6M
ArmR: a novel drug target and mediator of antibiotic resistanceR21AI098800 · NIAID · EMORY UNIVERSITY · PI WEISS, DAVID S · 2012 to 2013
$473k
Phase variable control of Acinetobacter baumannii virulenceR21AI115183 · NIAID · EMORY UNIVERSITY · PI RATHER, PHILIP N. · 2015 to 2016
$350k
BLRD VA I01 BX001725BLRD VA I01 BX002788BLRD VA IK6 BX004470NCATS NIH HHS UL1 TR000454NCATS NIH HHS UL1 TR002378NIAID NIH HHS R21 AI098800NIAID NIH HHS R21 AI115183NIAID NIH HHS R33 AI098800NIH HHS P51 OD011132
6 · The paper itself

Abstract

Antibiotic-resistant infections lead to 700,000 deaths per year worldwide

Indexed as

Drug Resistance, BacterialAcinetobacter baumanniiAcinetobacter InfectionsAnimalsBacterial ProteinsCell LineDesiccationDisease Models, AnimalDisinfectantsGenetic VariationHumansMicePhenotypeVaccinationVirulenceBacterial ProteinsDisinfectants

Identifiers

PMID29693659
PMCPMC5921939
OpenAlexW2799644963

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.